Summary:
The purpose of this study is to assess safety and efficacy of BAY1817080 compared to elagolix and placebo in women with symptomatic endometriosis
Qualified Participants Must:
• Be 18 Years and older
•
Visually-confirmed endometriosis: detection of endometriotic lesions during laparoscopy or laparotomy
Qualified Participants May Receive:
Intervention/treatment: BAY1817080, Elagolix, or Placebo.
Payment for time and travel.